Trial NCT03371381

View at ClinicalTrials.gov 
Org. Study IDs: CR108232
Secondary IDs: 2016-002543-41 64041757LUC2002

Last trial update was posted on 2019-12-11

MeSH Interventions

Nivolumab

MeSH Conditions

Adenocarcinoma Adenocarcinoma of Lung

Other Conditions


Stopping Reasons

Development of JNJ-64041757 in combination with nivolumab discontinued due to lack of clinical benefit observed in the Phase 1b portion of the study

Limitations And Caveats

Sponsor did not proceed to Randomized phase 2 of study or enroll additional participants in phase 1b as study was stopped early, that resulted in limited evaluation of planned participant-related outcomes, PK, immunogenicity and biomarker analyses.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID